rs144539316
Positions:
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM2BP4_StrongBP6BS1
The NM_001164508.2(NEB):c.19219G>A(p.Glu6407Lys) variant causes a missense change. The variant allele was found at a frequency of 0.000148 in 1,610,612 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.00073 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000088 ( 0 hom. )
Consequence
NEB
NM_001164508.2 missense
NM_001164508.2 missense
Scores
6
13
Clinical Significance
Conservation
PhyloP100: 3.91
Genes affected
NEB (HGNC:7720): (nebulin) This gene encodes nebulin, a giant protein component of the cytoskeletal matrix that coexists with the thick and thin filaments within the sarcomeres of skeletal muscle. In most vertebrates, nebulin accounts for 3 to 4% of the total myofibrillar protein. The encoded protein contains approximately 30-amino acid long modules that can be classified into 7 types and other repeated modules. Protein isoform sizes vary from 600 to 800 kD due to alternative splicing that is tissue-, species-,and developmental stage-specific. Of the 183 exons in the nebulin gene, at least 43 are alternatively spliced, although exons 143 and 144 are not found in the same transcript. Of the several thousand transcript variants predicted for nebulin, the RefSeq Project has decided to create three representative RefSeq records. Mutations in this gene are associated with recessive nemaline myopathy. [provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -7 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.010177702).
BP6
Variant 2-151560687-C-T is Benign according to our data. Variant chr2-151560687-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 449852.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Uncertain_significance=3}.
BS1
Variant frequency is greater than expected in population afr. gnomad4_exome allele frequency = 0.0000878 (128/1458390) while in subpopulation AFR AF= 0.0032 (107/33418). AF 95% confidence interval is 0.00271. There are 0 homozygotes in gnomad4_exome. There are 52 alleles in male gnomad4_exome subpopulation. Median coverage is 31. This position pass quality control queck.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NEB | NM_001164507.2 | c.19219G>A | p.Glu6407Lys | missense_variant | 124/182 | ENST00000427231.7 | NP_001157979.2 | |
NEB | NM_001164508.2 | c.19219G>A | p.Glu6407Lys | missense_variant | 124/182 | ENST00000397345.8 | NP_001157980.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NEB | ENST00000397345.8 | c.19219G>A | p.Glu6407Lys | missense_variant | 124/182 | 5 | NM_001164508.2 | ENSP00000380505.3 | ||
NEB | ENST00000427231.7 | c.19219G>A | p.Glu6407Lys | missense_variant | 124/182 | 5 | NM_001164507.2 | ENSP00000416578.2 |
Frequencies
GnomAD3 genomes AF: 0.000736 AC: 112AN: 152104Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
112
AN:
152104
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000172 AC: 42AN: 244100Hom.: 0 AF XY: 0.000136 AC XY: 18AN XY: 132090
GnomAD3 exomes
AF:
AC:
42
AN:
244100
Hom.:
AF XY:
AC XY:
18
AN XY:
132090
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000878 AC: 128AN: 1458390Hom.: 0 Cov.: 31 AF XY: 0.0000717 AC XY: 52AN XY: 725104
GnomAD4 exome
AF:
AC:
128
AN:
1458390
Hom.:
Cov.:
31
AF XY:
AC XY:
52
AN XY:
725104
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000729 AC: 111AN: 152222Hom.: 0 Cov.: 32 AF XY: 0.000793 AC XY: 59AN XY: 74420
GnomAD4 genome
AF:
AC:
111
AN:
152222
Hom.:
Cov.:
32
AF XY:
AC XY:
59
AN XY:
74420
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
11
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
27
Asia WGS
AF:
AC:
2
AN:
3478
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:3
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:2Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Oct 08, 2021 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Apr 18, 2023 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | May 19, 2024 | In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 26, 2024 | The c.14116G>A (p.E4706K) alteration is located in exon 97 (coding exon 95) of the NEB gene. This alteration results from a G to A substitution at nucleotide position 14116, causing the glutamic acid (E) at amino acid position 4706 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
NEB-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 20, 2023 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Nemaline myopathy 2 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 24, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;.;T;.;T;T;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D;D;D;D;.;.
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;.;.;.;L;.;.;.
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;.;N;N;N;.;.
REVEL
Benign
Sift
Benign
T;T;.;T;T;T;.;.
Sift4G
Benign
T;T;T;T;T;T;T;T
Polyphen
0.0060
.;.;.;.;B;.;.;.
Vest4
MVP
MPC
0.071
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at